VEGFA and retinopathy of prematurity: Although the pathogenesis of ROP is poorly understood, vascular endothelial growth factor (VEGF) is found to play an essential role in the ROP development,[5,6] because dysregulation of VEGF causes abnormality in vasculogenesis and neovascularization.[7–9] Over past few decades, treatment with laser therapy (LT) has been reported to manage such condition and prevent blindness by suppressing overproduction of VEGF in the retina.[10–12] It also helps induce the regression of new vessels by ablating peripheral retina ischemic areas.[11–13]